188 related articles for article (PubMed ID: 8498903)
1. A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column.
Gejyo F; Homma N; Hasegawa S; Arakawa M
Artif Organs; 1993 Apr; 17(4):240-3. PubMed ID: 8498903
[TBL] [Abstract][Full Text] [Related]
2. A new treatment for dialysis-related amyloidosis with beta 2-microglobulin adsorbent column.
Nakazawa R; Azuma N; Suzuki M; Nakatani M; Nankou T; Furuyoshi S; Yasuda A; Takata S; Tani N; Kobayashi F
Int J Artif Organs; 1993 Dec; 16(12):823-9. PubMed ID: 8175198
[TBL] [Abstract][Full Text] [Related]
3. Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis.
Suzuki K; Shimazaki M; Kutsuki H
Ther Apher Dial; 2003 Feb; 7(1):104-7. PubMed ID: 12921124
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis.
Gejyo F; Teramura T; Ei I; Arakawa M; Nakazawa R; Azuma N; Suzuki M; Furuyoshi S; Nankou T; Takata S
Artif Organs; 1995 Dec; 19(12):1222-6. PubMed ID: 8967878
[TBL] [Abstract][Full Text] [Related]
5. [Beta 2-microglobulin and dialysis-related amyloidosis].
Gejyo F
Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
[TBL] [Abstract][Full Text] [Related]
6. beta(2)-Microglobulin-selective direct hemoperfusion column for the treatment of dialysis-related amyloidosis.
Kutsuki H
Biochim Biophys Acta; 2005 Nov; 1753(1):141-5. PubMed ID: 16168723
[TBL] [Abstract][Full Text] [Related]
7. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
8. New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion.
Furuyoshi S; Nakatani M; Taman J; Kutsuki H; Takata S; Tani N
Ther Apher; 1998 Feb; 2(1):13-7. PubMed ID: 10227783
[TBL] [Abstract][Full Text] [Related]
9. Historical background and clinical treatment of dialysis-related amyloidosis.
Yamamoto S; Gejyo F
Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
[TBL] [Abstract][Full Text] [Related]
10. Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.
Gejyo F; Amano I; Ando T; Ishida M; Obayashi S; Ogawa H; Ono T; Kanno Y; Kitaoka T; Kukita K; Kurihara S; Sato M; Shin J; Suzuki M; Takahashi S; Taguma Y; Takemoto Y; Nakazawa R; Nakanishi T; Nakamura H; Hara S; Hiramatsu M; Furuya R; Masakane I; Tsuchida K; Motomiya Y; Morita H; Yamagata K; Yoshiya K; Yamakawa T;
Ther Apher Dial; 2013 Feb; 17(1):40-7. PubMed ID: 23379492
[TBL] [Abstract][Full Text] [Related]
11. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.
Hiyama E; Hyodo T; Kondo M; Otsuka K; Honma T; Taira T; Yoshida K; Uchida T; Endo T; Sakai T; Baba S; Hidai H
Nephron; 2002 Oct; 92(2):501-2. PubMed ID: 12218344
[No Abstract] [Full Text] [Related]
12. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
Abe T; Uchita K; Orita H; Kamimura M; Oda M; Hasegawa H; Kobata H; Fukunishi M; Shimazaki M; Abe T; Akizawa T; Ahmad S
Kidney Int; 2003 Oct; 64(4):1522-8. PubMed ID: 12969174
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
Yamamoto Y; Hirawa N; Yamaguchi S; Ogawa N; Takeda H; Shibuya K; Kawahara K; Kojima H; Dobashi Y; Fujita M; Azusima K; Miyazaki N; Kobayashi M; Kobayashi C; Fujiwara A; Yuto J; Saka S; Yatsu K; Toya Y; Yasuda G; Ohnishi T; Umemura S
Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
Kopeć J
Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
[TBL] [Abstract][Full Text] [Related]
15. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
Gejyo F; Kawaguchi Y; Hara S; Nakazawa R; Azuma N; Ogawa H; Koda Y; Suzuki M; Kaneda H; Kishimoto H; Oda M; Ei K; Miyazaki R; Maruyama H; Arakawa M; Hara M
Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
[TBL] [Abstract][Full Text] [Related]
16. Nontransplant therapy for dialysis-related amyloidosis.
Copley JB; Lindberg JS
Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
[TBL] [Abstract][Full Text] [Related]
17. Beta 2-microglobulin amyloidosis in chronic dialysis patients: a case report and review of the literature.
Farrell J; Bastani B
J Am Soc Nephrol; 1997 Mar; 8(3):509-14. PubMed ID: 9071720
[TBL] [Abstract][Full Text] [Related]
18. Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients.
Gejyo F; Narita I
Nephrology (Carlton); 2003 Oct; 8 Suppl():S45-9. PubMed ID: 15012691
[TBL] [Abstract][Full Text] [Related]
19. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
Jaradat MI; Moe SM
Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
[TBL] [Abstract][Full Text] [Related]
20. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
